Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 544K | n/a | n/a | n/a | 2.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 272K | n/a | 135K | 137K | 135K | 455K | 491K | n/a | 469K | 451K | 440K | 448K | 329K | 136K | 122K | 98K |
Gross Profit | n/a | n/a | 272K | n/a | -135K | -137K | 2.71M | -455K | -491K | n/a | -469K | -451K | -440K | -448K | -329K | -136K | -122K | -98K |
Operating Income | -5.21M | -7.27M | -8.27M | -7.82M | -7.79M | -8.73M | -8.14M | -7.74M | -10.18M | -11.01M | -13.05M | -13.94M | -10.71M | -12.49M | -9.41M | -10.32M | -9.78M | -7.97M |
Interest Income | 321K | 405K | 522K | 591K | 669K | 768K | 826K | 877K | 952K | 969K | 609K | 515K | 349K | 310K | 334K | 278K | 188K | n/a |
Pretax Income | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.23M | -13.42M | -10.54M | -12.4M | -9.37M | -9.69M | -9.77M | -7.97M |
Net Income | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.44M | -12.89M | -10.36M | -12.32M | -9.37M | -9.69M | -9.77M | -7.97M |
Selling & General & Admin | 2.67M | 3.55M | 2.83M | 3.19M | 3.2M | 3.68M | 3.51M | 3.92M | 5.39M | 5.8M | 5.7M | 4.75M | 4.32M | 5.03M | 3.46M | 3.87M | 3.89M | 4.6M |
Research & Development | 2.53M | 3.73M | 4.49M | 4.64M | 4.58M | 4.92M | 4.49M | 3.82M | 4.78M | 5.2M | 7.34M | 9.19M | 6.39M | 7.46M | 5.96M | 6.44M | 5.9M | 3.37M |
Other Expenses | n/a | n/a | 951K | n/a | n/a | -2K | -67K | 613K | 68K | n/a | 1.56M | 20K | n/a | n/a | n/a | 631K | -28K | -3K |
Operating Expenses | 5.21M | 7.27M | 7.46M | 7.82M | 7.79M | 8.59M | 8.01M | 7.74M | 10.18M | 11.01M | 13.05M | 13.94M | 10.71M | 12.49M | 9.41M | 10.32M | 9.78M | 7.97M |
Interest Expense | -10K | -13K | 17K | 21K | 24K | 28K | 31K | 33K | 38K | 42K | n/a | 10K | 172K | 243K | 306K | 214K | 147K | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -137K | -135K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 7.27M | 8.27M | 7.82M | 7.79M | 8.73M | 8.14M | 7.74M | 10.18M | 11.01M | 13.05M | 13.94M | 10.71M | 12.49M | 9.41M | 10.32M | 9.78M | 7.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 209K | -525K | -177K | -82K | -47K | n/a | -13K | 3K |
Shares Outstanding (Basic) | 1.26B | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M | 30.59M | 30.59M | 18.9M |
Shares Outstanding (Diluted) | 1.26B | 25.19M | 25.17M | 25.15M | 25.1M | 25.05M | 25.03M | 25.51M | 30.51M | 30.87M | 30.74M | 30.72M | 30.7M | 30.65M | 30.59M | 30.59M | 30.59M | 18.9M |
EPS (Basic) | -3.91 | -0.27 | -0.31 | -0.29 | -0.28 | -0.32 | -0.3 | -0.28 | -0.31 | -0.33 | -0.4 | -0.42 | -0.34 | -0.4 | -0.31 | -0.32 | -0.32 | -0.42 |
EPS (Diluted) | -3.91 | -0.27 | -0.31 | -0.29 | -0.28 | -0.32 | -0.3 | -0.28 | -0.31 | -0.33 | -0.4 | -0.42 | -0.34 | -0.4 | -0.31 | -0.32 | -0.32 | -0.42 |
EBITDA | -5.21M | -6.82M | -7.61M | -6.9M | -6.98M | -7.83M | -7.25M | -6.64M | -8.86M | -9.78M | -12.7M | -12.96M | -9.92M | -11.71M | -8.73M | -9.34M | -9.5M | -7.87M |
EBIT | n/a | -6.85M | -7.75M | -7.23M | -7.12M | -7.96M | -7.38M | -7.09M | -9.35M | -10.13M | -12.44M | -13.41M | -10.36M | -12.16M | -9.06M | -9.47M | -9.62M | -7.97M |
Depreciation & Amortization | n/a | n/a | 139K | 332K | 328K | 137K | 135K | 455K | 491K | 358K | 469K | 451K | 440K | 448K | 329K | 136K | 122K | 98K |